AI Right! Founders Series: TileBio with co-founders Dr. Christopher Walsh and Professor John Le Quesne.
In this episode, we explore the journey of TileBio, a health tech startup focused on revolutionizing cancer diagnostics through AI. Co-founders Dr. Christopher Walsh and Professor John Le Quesne share their backgrounds in computer science and pathology, respectively, and discuss how their diverse expertise drives the company's mission to address the pathologist shortage.
They delve into the technology behind TileBio, including self-supervised learning and the importance of collaboration between medical and AI professionals. The conversation also covers the company's growth strategy, funding, and plans for global expansion, emphasizing the need for user-friendly solutions that enhance the workflow of pathologists.
Hosted on Acast. See acast.com/privacy for more information.
